August 6, 2007
Galvus Recommended for European Approval: Novartis Novartis AG announced on July 23 through Novartis Pharma that the oral medication for type 2 diabetes Galvus (vildagliptin) has been recommended for approval in the EU. In Japan, Novartis Pharma is conducting a...read more